Release date: 2012-09-28


Abbott announced on September 25 that it will launch the world's first drug-eluting bioresorbable vascular scaffold (BVS), Absorb, in Europe, parts of Asia Pacific and Latin America. A revolutionary change in the treatment of coronary artery disease (CAD).

Healthcare giant Abbott Absorb is the first bioabsorbable drug-eluting stent that works like a metal stent, which works to restore coronary blood flow (CAD) by restoring blood flow. With a permanent metal stent, Absorb dissolves in the body over time, leaving only one treated blood vessel, allowing the blood vessels to return to more natural functions and movements.
Absorb is made from a naturally decomposable material, polylactic acid, which is commonly used in medical implants such as dissolution sutures.
A soluble stent, the potential long-term benefits are very significant. Normally, blood vessels expand or contract when needed to increase blood flow back to the heart to cope with normal life activities (such as exercise). Absorb expands the treatment and diagnostic options for CAD and is expected to reduce the need for long-term anticoagulant drugs, while future interventions will not be subject to a permanent implant.
“This innovation represents a true paradigm shift in our treatment of coronary artery disease. Absorb makes the dream of autonomic disappearance of the vascular stent disappearing after completing the task,” Interventional Cardiology at Erasmus University Hospital, Rotterdam, The Netherlands Professor Patrick W. Serruys said. “Absorb is very attractive for CAD patients because it restores blood vessels to a more natural state while expanding long-term diagnostic and therapeutic options.”
Absorb's launch is based on a strong clinical trial project that includes five studies involving more than 20 countries around the world. Research data shows that Absorb's performance is comparable to that of world-class drug-eluting stents, while providing patients with additional benefits. The stent dissolves over time, allowing the function of the blood vessels to recover, making more Blood flows through the blood vessels to meet the needs of the body.
Heart disease is the leading cause of death worldwide, with coronary artery disease (CAD) being the most common type. When the arteries supplying blood to the heart become narrow or clogged, CAD occurs, which can lead to chest pain or shortness of breath, increasing the risk of heart attack, the myocardial infarction.

Source: China Medical Technology Network

Omega-3 Refined Fish Oil

Omega-3 Refined Fish Oil,Omega Refined Fish Oil,Refined Fish Oil 30/20Tg,Refined Fish Oil

ZHOUSHAN SINOMEGA BIOTECH ENGINEERING CO.,LTD , https://www.sinomegabiotech.com